OFFICIAL ROYAL PEPTIDES WEBSITE You are on royal-peptides.com
VERIFY OFFICIAL SITE

Royal Peptides

ROYAL RESEARCH CATALOG

Wolverine BPC-157 TB-500 Blend BB

Research Material Batch Documentation Secure Checkout
Price range: $75 through $695
Choose an option
Clear selection
BUY MORE • SAVE MORE Volume Pricing
Standard pricing
10+Shop Kits10-vial kits →
01Research focusedLaboratory research materials
02DocumentedAvailable batch information
03TrackedOrder fulfillment updates
Secure payment VISA link $ ₿
RESEARCH NOTICE
For laboratory and research purposes only.Not intended for human consumption, diagnostic use, therapeutic use, or administration to humans or animals.
View Documentation →
Research Material • WOLVERINE™ 20 mg

WOLVERINE™ 20 mg Research Peptide Blend

WOLVERINE™ is a defined two-component lyophilized research blend containing BPC-157 and TB-500 in a balanced 20 mg formulation, supplied by Royal Peptides exclusively for controlled laboratory, analytical, and scientific research applications.

2-Component Blend 20 mg Total 10 mg + 10 mg Lyophilized Material Batch Traceability
Research Use Only

Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.

01
Blend Profile

WOLVERINE™ Research Material

Royal Peptides WOLVERINE™ is a defined multi-component research preparation combining BPC-157 and TB-500 within a single lyophilized vial.

Each vial contains a total of 20 mg of research material: 10 mg BPC-157 and 10 mg TB-500. The equal-component formulation provides a clearly identified 1:1 quantitative composition for laboratory research and analytical documentation.

WOLVERINE™ is supplied strictly as a laboratory research material. References to its individual components or scientific literature are provided solely for compound identification, analytical context, and research documentation.

02
Defined Composition

WOLVERINE™ 20 mg Blend Composition

WOLVERINE™ combines two separately identifiable peptide research materials at equal stated quantities within a single lyophilized research preparation.

BPC-157 10 mg Peptide research component
TB-500 10 mg Peptide research component
Total Research Material Per Vial 20 mg
03
Component Identification

Two-Component Research Formulation

The two components of WOLVERINE™ are independently identifiable research materials. The descriptions below are provided for material identification and scientific research context only.

BPC-157 • 10 mg

Synthetic peptide research material incorporated at a defined 10 mg quantity within the WOLVERINE™ formulation.

TB-500 • 10 mg

Peptide research material incorporated at a defined 10 mg quantity as the second component of the formulation.

Balanced Composition

Each component represents an equal stated quantity within the formulation, producing a documented 10:10 mg composition.

Defined Research Material

Combining both identified materials in one preparation provides laboratories with a defined multi-component sample for appropriately designed research workflows.

04
Research Environment

Controlled Multi-Component Research

WOLVERINE™ is intended for controlled laboratory environments where defined multi-component peptide materials are required for analytical, comparative, or experimental research workflows.

Analytical Characterization

Appropriate analytical methods may be used to investigate material identity, composition, purity, and other measurable characteristics of the research sample.

Multi-Component Analysis

The formulation provides two identified peptide research materials within one defined laboratory sample.

Comparative Research

Qualified laboratories may incorporate the material into appropriately designed comparative or reference-based experimental systems.

Laboratory Documentation

Defined composition, product identification, lot information, and applicable analytical records support material traceability.

05
Quality Documentation

Batch-Specific Analytical Information

Research evaluation should rely on documentation associated with the specific WOLVERINE™ production lot under investigation. General product-page information should not replace applicable batch-specific analytical documentation.

  • Blend and component identification
  • Production lot or batch reference
  • Declared component quantities
  • Analytical testing information
  • Purity information where applicable
  • Testing methodology where documented
  • Certificate of Analysis information where available
  • Research material traceability
06
Traceability

Research Records & Batch Control

Maintaining clear laboratory records helps associate analytical observations with the specific WOLVERINE™ production lot used within an experimental workflow.

Material Identification

Record the WOLVERINE™ product identifier, stated BPC-157 and TB-500 composition, applicable lot reference, date received, and internal laboratory reference information.

Analytical Records

Preserve applicable analytical documentation, laboratory observations, experimental results, storage records, and internal research documentation.

07
Laboratory Protocol

Handling & Storage

Professional Laboratory Handling

WOLVERINE™ should be handled by personnel familiar with appropriate laboratory procedures, contamination control, research-material identification, and laboratory safety practices.

Storage & Records

Follow storage information associated with the applicable product label and batch documentation. Maintain appropriate laboratory storage and material-control records.

08
Important Restrictions

Research Use Limitations

Royal Peptides WOLVERINE™ is supplied exclusively as a laboratory research material. It is not offered or represented as a medicine, pharmaceutical preparation, dietary supplement, food, cosmetic, or consumer health product.

  • Not for human administration
  • Not for veterinary administration
  • Not for ingestion or injection
  • Not for personal experimentation
  • Not for pharmaceutical compounding
  • Not for pharmacy preparation
  • Not for diagnostic or therapeutic use
  • Not for clinical use
09
Research FAQ

WOLVERINE™ Research Questions

What is WOLVERINE™ 20 mg?

WOLVERINE™ is a two-component lyophilized research blend supplied by Royal Peptides for controlled laboratory, analytical, and scientific research.

What does WOLVERINE™ contain?

Each vial contains 10 mg BPC-157 and 10 mg TB-500, providing a total stated research-material content of 20 mg.

What is the component ratio?

WOLVERINE™ contains equal stated quantities of BPC-157 and TB-500: 10 mg of each component, producing a 1:1 quantitative formulation.

Is WOLVERINE™ a single peptide?

No. WOLVERINE™ is a multi-component research formulation containing two identified peptide research materials within one lyophilized vial.

Is WOLVERINE™ intended for human use?

No. Royal Peptides supplies WOLVERINE™ strictly for laboratory research. It is not intended for human or veterinary administration.

Does Royal Peptides provide dosing instructions?

No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for WOLVERINE™ or its individual research components.

Why is the batch number important?

Batch-specific analytical documentation corresponds to a particular production lot. Recording the applicable lot reference supports traceability between the research material, analytical documentation, and laboratory records.

Is analytical documentation available?

Batch-specific analytical documentation may be available for the applicable production lot. Researchers should review documentation corresponding to the specific material received.

Research Use Only

Laboratory Research Material

WOLVERINE™ is supplied for laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, pharmaceutical compounding, pharmacy preparation, diagnostic use, therapeutic use, or clinical use. Nothing on this page constitutes medical advice or represents this research material as intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

0